Anzeige
Mehr »
Freitag, 27.06.2025 - Börsentäglich über 12.000 News
Ein echter Gamechanger: Diese News kann den Grundstein für eine Neubewertung der Rock-Tech-Aktie legen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JAWQ | ISIN: CNE1000012B3 | Ticker-Symbol: S1R
Tradegate
24.06.25 | 13:19
1,310 Euro
+0,77 % +0,010
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI PHARMACEUTICALS HOLDING CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI PHARMACEUTICALS HOLDING CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,2601,31026.06.
1,2701,32026.06.

Aktuelle News zur SHANGHAI PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoSH PHARMA (02607): FINAL DIVIDENDS FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED)2
DoSH PHARMA (02607): RESULTS OF THE ANNUAL GENERAL MEETING AND RECORD DATE FOR DISTRIBUTION AND RECEIPT OF CASH DIVIDENDS-
18.06.SH PHARMA (02607): INDICATIVE ANNOUNCEMENT ON THE CONVENING OF THE ANNUAL GENERAL MEETING-
28.05.SH PHARMA (02607): FINAL DIVIDENDS FOR THE YEAR ENDED 31 DECEMBER 2024 (UPDATED)1
28.05.SH PHARMA (02607): REPLY SLIP FOR HOLDERS OF H SHARE ATTENDING THE ANNUAL GENERAL MEETING1
SHANGHAI PHARMACEUTICALS Aktie jetzt für 0€ handeln
28.05.SH PHARMA (02607): PROXY FORM OF HOLDERS OF H SHARES FOR USE AT THE ANNUAL GENERAL MEETING-
28.05.SH PHARMA (02607): NOTICE OF ANNUAL GENERAL MEETING1
28.05.SH PHARMA (02607): ANNUAL REPORT FOR 2024 REPORT OF THE BOARD OF DIRECTORS FOR 2024 REPORT OF THE BOARD OF SUPERVISORS FOR 2024 FINAL ACCOUNTS REPORT ...1
27.05.Novartis expands strategic collaboration with Shanghai Pharma in China to cover eye drugs9
28.04.SH PHARMA (02607): 2025 FIRST QUARTERLY REPORT-
25.04.SH PHARMA (02607): 2024 SUSTAINABILITY REPORT & ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT-
25.04.SH PHARMA (02607): 2024 ANNUAL REPORT1
14.04.SH PHARMA (02607): UPDATE ON CONNECTED TRANSACTION PROPOSED PARTICIPATION IN THE ESTABLISHMENT OF THE BIOMEDICAL M&A FUND2
14.04.SH PHARMA (02607): NOTICE OF BOARD MEETING3
27.03.SH PHARMA (02607): FINAL DIVIDENDS FOR THE YEAR ENDED 31 DECEMBER 2024-
27.03.SH PHARMA (02607): 2024 ANNUAL RESULTS ANNOUNCEMENT-
27.03.SH PHARMA (02607): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
27.03.SH PHARMA (02607): CHANGE IN COMPOSITION OF THE BOARD COMMITTEE1
27.03.SH PHARMA (02607): IMPLEMENTATION RULES OF THE NOMINATION COMMITTEE OF THE BOARD OF DIRECTORS-
21.03.SH PHARMA (02607): ANNOUNCEMENT ON THE RECEIPT OF A DECISION OF ADMINISTRATIVE PENALTY BY A SUBSIDIARY-
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1